Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v1-EN
Language English English
Date Updated 2017-10-28 2017-06-30
Drug Identification Number 02139510 02139510
Brand name SODIUM CHLORIDE INJECTION, USP SODIUM CHLORIDE INJECTION, USP
Common or Proper name Sodium Chloride Injection Sodium Chloride Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients SODIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 234MG 234MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 200mL 200mL
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-07-03 2017-07-03
Actual start date
Estimated end date 2017-11-01 2017-08-31
Actual end date 2017-10-27
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments We have resolved our supply interruption and replenishment inventories at all distribution centers, effective today. During this period, our 100 mL format will be available for substitution.
Health Canada comments